Keywords: summit, evolva, deal, smt, corp, uk, drug

Summit and Evolva in deal for SMT 14400

Article | 12 January 2009

Print This

Summit Corp, a UK drug discovery company, has entered into an exclusive worldwide licensing agreement with the Swiss company, Evolva ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in